Home About Us Contact Us

 

Table of Content - Volume 4 Issue 1- October 2016


Extra-intestinal manifestations of ulcerative colitis

 

Ashish R Bhootra1, Samil Sajal2*, Rekha S Patil3, Y K Boliya4, Santosh D Hajare5

 

1Consultant Physician, Metas Adventist Hospital, Surat, Gujarat, INDIA.

2Assistant Professor, 4Professor and HOD, Department of Medicine, Pacific Medical College and Hospital billion Ka Bedla, Pratap Pura Near national highway number 76, girwa, Udaipur 313011, Rajasthan, INDIA.

3Professor and HOD, Department of Medicine Jawaharlal Nehru Medical College Belgaum, Karnataka, INDIA.

5Culsultatant, Department of Gastroenterology, Jawaharlal Nehru Medical College, Balgaum, Karnataka, INDIA.

Email: samilsajal@gmail.com

 

REFERENCES

  1. Hendrickson BA, Gokhale R, Cho JH. Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease. Clinical Microbiology Reviews 2002;15(1):79-94.
  2. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF.Ulcerative colitis.Lancet. 2017 Apr 29; 389(10080):1756-1770.
  3. Khosla SN, Girdhar NK, Lal S, Mishra DS: Epidemiology of ulcerative colitis in hospital and select general population of northern India. J Assoc Physicians India 1986; 34: 405–407.
  4. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003; 52(11):1587-90.
  5. Ardizzone S, Puttini PS, Cassinotti A, et al.Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis. 2008; 40(suppl 2):S253–S259.
  6. Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44(1): 1-13.
  7. Ozdil S, Akyuz F, et al. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepatogastroenterology 2004; 51(57):768-770.
  8. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006;12:4819–4831.
  9. Ott C, Scholmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev GastroenterolHepatol. 2013; 10:585–595.
  10. Makharia GK, Ramakrishna BS, Abraham P, et al; Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease: Survey of inflammatory bowel diseases in India. Indian J Gastroenterol 2012; 31:299–306.
  11. Pokharna RK, Kabra PK, Sharma R, et al. Extraintestinal manifestations of idiopathic ulcerative colitis in northwestern India. Indian J Gastroenterol 2004; 23:89–90.
  12. Sood A, Midha V, Sood N, Kaushal V, Puri S. Profile of Ulcerative Colitis in a North Indian Hospital. J Indian AcadClin Med 2000; 5(2):124-8.
  13. Kedia S, Ahuja V. Epidemiology of inflammatory bowel disease in India: the Great Shift. East.InflammIntest Dis. Published online: April 8, 2017 https://doi.org/10.1159/000465522.
  14. Singh B, Kedia S, Konijeti G, et al.Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: frequency and relation with disease phenotype. Indian J Gastroenterol 2015; 34:43–50.
  15. Kochhar R, Mehta SK, Nagi B, et al. Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J Gastroenterol. 1991; 10:88–9.
  16. Pokharna RK, Kabra PK, Sharma R, et al. Extraintestinal manifestations of idiopathic ulcerative colitis in northwestern India. Indian J Gastroenterol. 2004; 23:89–90.
  17. Bandyopadhyay D, Bandyopadhyay S, Ghosh P, et al.Extraintestinal manifestations in inflammatory bowel disease: prevalence and predictors in Indian patients. Indian J Gastroenterol 2015; 34:387–394.
  18. Brakenhoff LK, van der Heijde DM, Hommes DW. IBD and arthropathies: a practical approach to its diagnosis and management. Gut. 2011; 60:1426–1435.
  19. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011; 106:110–119.
  20. De Vos M. Review article: Joint involvement in inflammatory bowel disease. Aliment PharmacolTher. 2004; 20 Suppl 4:36–42.
  21. Menachem Y, Gotsman I. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease. Isr Med Assoc J. 2004; 6:88–90.
  22. Farhi D, Cosnes J, Zizi N, et al.. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine. 2008; 87:281–293.
  23. Timani S, Mutasim DF. Skin manifestations of inflammatory bowel disease. ClinDermatol 2008; 26:265–273.
  24. Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, Grisar J, Machold K, Scholz S, Vogelsang H, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004; 53:542–548.
Journal Menu MIJOMED Medpulse Manuscript Submission Subscription Aim & Scope Peer Review Process Publication Ethics & Malpractice Statement Open Access Statement Plagiarism Policy Editorial Board Indexing Current Issue Publication Charges Archives Authors Information Copyright & Licensing Privacy Statement Contact Us